April 23, 2021 The research team of Etsuko Miyamoto-Sato, a professor at the Tokyo University of Science Research Institute, who is also a director of our company, created a compound that induces the degradation of mutant KRAS using chemical knockdown technology. We confirmed the effectiveness in vivo and reported the research results to bioRxiv.
2021.4.23
On April, 2021, FuturedMe had report the research results to the preprint server bioRxiv.